Comparison of Latanoprost, Travoprost, and Bimatoprost on Adherence, Persistence, and Pattern of Initial Therapy in Glaucoma and Ocular Hypertension: An Administrative Claims Database Analysis [PDF]
JH Heo, KL Rascati
openalex +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response. [PDF]
Bello NR +7 more
europepmc +1 more source
Abstract Aims The study aims to evaluate the effects of exercise‐based cardiac rehabilitation (ExCR) on the health‐related quality of life (HRQoL) in people with heart failure preserved ejection fraction (HFpEF). Methods This study is a systematic review and meta‐analysis.
Chenyao Ding, Yawen Gao, Rod S. Taylor
wiley +1 more source
From tumor microenvironment to ocular hypertension: unraveling the pathogenesis and therapeutic strategies of cancer-related glaucoma. [PDF]
Lin B, Li DK.
europepmc +1 more source
The QUAD score was developed to promote adherence to clinical practice guidelines for patients with heart failure and a reduced left ventricular ejection fraction <50%. In newly diagnosed patients who had completed therapy titration, we found that patients with an excellent QUAD score had a significant reduction in the risk of mortality or ...
Henry Oluwasefunmi Savage +23 more
wiley +1 more source
Citicoline and Coenzyme Q10: Therapeutic Agents for Glial Activation Reduction in Ocular Hypertension. [PDF]
Matamoros JA +14 more
europepmc +1 more source
Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis
Marcus Ang
openalex +2 more sources
Efficacy and tolerability of mono-compound topical treatments for reduction of intraocular pressure in patients with primary open angle glaucoma or ocular hypertension: an overview of reviews [PDF]
Qendresë Daka, Vladimir Trkulja
openalex +1 more source
Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study
Abstract Aims Inflammation is postulated to be a key pathogenic mechanism in heart failure with preserved ejection fraction (HFpEF). Soluble urokinase plasminogen activator receptor (suPAR), a regulator of innate immune activity, is associated with incident heart failure; however, its role in HFpEF remains unclear.
Christina G. Hutten +9 more
wiley +1 more source

